Editor's Note In an October 26 news release, ECRI announced the publication of a Position Statement on “COVID-19 Vaccines: Mitigating Disease and Promoting Global Health Equity.” Speaking in support of the Statement, Marcus Schabacker, MD, PhD, president and chief executive officer, ECRI, says: “Despite the FDA and CDC’s advancement of…

Read More

Editor's Note The Centers for Disease Control and Prevention (CDC) director Rochelle P. Walensky, MD, MPH, on October 21, endorsed the CDC Advisory Committee on Immunization Practices’ recommendation for a booster of COVID-19 vaccines in certain populations. For individuals who received Pfizer-BioNTech or Moderna COVID-19 vaccines, the following are eligible…

Read More

Editor's Note This study by researchers at Yale University School of Medicine, New Haven, Connecticut, identifies three themes centered on trust and addressing barriers to COVID-19 vaccine access in Black and Latinx communities in the US. The study involved 72 participants—56 women, 16 men, 36 Black, 28 Latinx, and 8…

Read More

Editor's Note The Centers for Disease Control and Prevention’s National Institute for Occupational Safety and Health (NIOSH) is seeking comments on workplace and occupational safety and health interventions to prevent work-associated stress, support stress reduction, and foster positive mental health and well-being among healthcare workers. Examples of interventions include employee…

Read More

Editor's Note This study from the Centers for Disease Control and Prevention finds that the percentage of US adults with anxiety and depression symptoms increased nationwide during the COVID-19 pandemic (August 19, 2020 to June 7, 2021). Using US Census Bureau Household Pulse Survey (HPS) data, the CDC found that…

Read More

Editor's Note In this study, researchers from Northwestern Memorial Hospital and Feinberg School of Medicine, Chicago, find that more healthcare workers (HCWs) were exposed to COVID-19 by coworkers than patients, and lapses in infection prevention practices increased transmission risk. Between June and December 2020, 2,357 HCWs were involved in occupational…

Read More

Editor's Note This study by researchers at the Centers for Disease Control and Prevention finds that adverse reactions after the third dose of Pfizer-BioNTech’s COVID-19 vaccine were similar to those after the second dose. Of 12,591 participants who completed a survey after all three doses: 79.4% and 74.1% reported local…

Read More

Editor's Note This study by Israeli researchers finds that restrictions implemented during COVID-19 dramatically altered daily routines and limited time spent outdoors, which resulted in deteriorating personal wellbeing. The analysis of 7,517 adults from 40 countries who were surveyed during the 2020 COVID-19 restrictions found that social restrictions impaired all…

Read More

Editor's Note In this study, Centers for Disease Control and Prevention (CDC) researchers report on the comparative effectiveness of COVID-19 vaccines against hospitalization of US adults without immunocompromised conditions. Included in the case-control analysis were 3,689 adults aged 18 years and older who were hospitalized at 21 US hospitals between…

Read More

Editor's Note A total of 95.19% of US counties are reporting high COVID-19 transmission rates, with at least 100 new cases per 100,000 people in the past 7 days, according to the Centers for Disease Control and Prevention. The surge in COVID-19 cases is being driven largely by the Delta…

Read More